menu
    • menu

    Find Treprostinil Sodium manufacturers, exporters & distributors on PharmaCompass

    Chirogate Treprostinil Sodium

    Virtual Booth

    Contact Supplier

    EuroAPI Treprostinil

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    Nuray Treprostinil Sodium

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass

    Synopsis

    Product SearchProduct Search

    Synopsis

    ACTIVE PHARMA INGREDIENTS

    28

    API Suppliers

    API Suppliers

    14

    USDMF

    US DMFs Filed

    0

    CEP/COS

    CEP/COS Certifications

    0

    JDMF

    JDMFs Filed

    4

    EU WC

    EU WC

    1

    KDMF

    KDMF

    13

    NDC API

    NDC API

    0

    VMF

    NDC API

    12

    Listed Suppliers

    Other Suppliers

    3INTERMEDIATES

    REF. STANDARDS OR IMPURITIES

    0

    EDQM

    0

    USP

    0

    JP

    0

    Others

    FINISHED DOSAGE FORMULATIONS

    119

    FDF Dossiers

    FDF Dossiers

    44

    FDA Orange Book

    FDA (Orange Book)

    67

    Europe

    Europe

    4

    Canada

    Canada

    0

    Australia

    Australia

    0

    South Africa

    South Africa

    4

    Listed Dossiers

    Listed Dossiers

    100DRUGS IN DEVELOPMENT

    FDF Dossiers

    DRUG PRODUCT COMPOSITIONS

    69RELATED EXCIPIENT COMPANIES

    121EXCIPIENTS BY APPLICATIONS

    PATENTS & EXCLUSIVITIES

    109

    US Patents

    8

    US Exclusivities

    0

    Health Canada Patents

    API REF. PRICE (USD/KG)

    $
    $ 351,725

    GLOBAL SALES INFORMATION

    US Medicaid

    455,508,841

    Annual Reports

    8,386

    Regulatory FDF Prices

    Listed Dossiers
    API/FDF Prices: Book a Demo to
    explore the features and consider
    upgrading later

    MARKET PLACE

    4

    API

    2

    FDF

    DIGITAL CONTENT

    1

    Data Compilation #PharmaFlow

    1

    Stock Recap #PipelineProspector

    0

    Weekly News Recap #Phispers

    70

    News #PharmaBuzz

    Chemistry

    Click the arrow to open the dropdown
    read-moreClick the button for full data set
    read-moreClick the button for full data set
    Also known as: 81846-19-7, Remodulin, Uniprost, Rumodolin, Orenitram, Tyvaso
    Molecular Formula
    C23H34O5
    Molecular Weight
    390.5  g/mol
    InChI Key
    PAJMKGZZBBTTOY-ZFORQUDYSA-N
    FDA UNII
    RUM6K67ESG
    Treprostinil Sodium
    Treprostinil is a synthetic analogue of prostacyclin, used to treat pulmonary hypertension.
    Treprostinil is a Prostacycline Vasodilator. The physiologic effect of treprostinil is by means of Vasodilation.
    1 2D Structure

    Treprostinil Sodium

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    2-[[(1R,2R,3aS,9aS)-2-hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[g]naphthalen-5-yl]oxy]acetic acid
    2.1.2 InChI
    InChI=1S/C23H34O5/c1-2-3-4-7-17(24)9-10-18-19-11-15-6-5-8-22(28-14-23(26)27)20(15)12-16(19)13-21(18)25/h5-6,8,16-19,21,24-25H,2-4,7,9-14H2,1H3,(H,26,27)/t16-,17-,18+,19-,21+/m0/s1
    2.1.3 InChI Key
    PAJMKGZZBBTTOY-ZFORQUDYSA-N
    2.1.4 Canonical SMILES
    CCCCCC(CCC1C(CC2C1CC3=C(C2)C(=CC=C3)OCC(=O)O)O)O
    2.1.5 Isomeric SMILES
    CCCCC[C@@H](CC[C@H]1[C@@H](C[C@H]2[C@@H]1CC3=C(C2)C(=CC=C3)OCC(=O)O)O)O
    2.2 Other Identifiers
    2.2.1 UNII
    RUM6K67ESG
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. ((1r,2r,3as,9as)-2-hydroxy-1-((3s)-3-hydroxyoctyl)-2,3,3a,4,9,9a-hexahydro-1h-cylopent(b)naphthalen-5-yl)oxy)acetate

    2. Orenitram

    3. Remodulin

    4. Trepostinil Sodium

    5. Treprostinil Diethanolamine

    6. Treprostinil Diolamin

    7. Treprostinil Diolamine

    8. Treprostinil Sodium

    9. Ut-15

    10. Ut-15c

    2.3.2 Depositor-Supplied Synonyms

    1. 81846-19-7

    2. Remodulin

    3. Uniprost

    4. Rumodolin

    5. Orenitram

    6. Tyvaso

    7. Lrx-15

    8. Ut-15

    9. 15au81

    10. Treprostinil Free Acid

    11. Rum6k67esg

    12. 2-(((1r,2r,3as,9as)-2-hydroxy-1-((s)-3-hydroxyoctyl)-2,3,3a,4,9,9a-hexahydro-1h-cyclopenta[b]naphthalen-5-yl)oxy)acetic Acid

    13. Chebi:50861

    14. 81846-19-7 (free Acid)

    15. ((1r,2r,3as,9as)-2-hydroxy-1-((3s)-3-hydroxyoctyl)-2,3,3a,4,9,9a-hexahydro-1h-cylopent(b)naphthalen-5-yl)oxy)acetate

    16. 2-[[(1r,2r,3as,9as)-2-hydroxy-1-[(3s)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1h-cyclopenta[g]naphthalen-5-yl]oxy]acetic Acid

    17. 289480-64-4

    18. 15-au-81

    19. L-606

    20. Treprostinilo

    21. Treprostinilum

    22. Lrx 15

    23. Treprostinil [usan:inn]

    24. Remodulin (tn)

    25. Unii-rum6k67esg

    26. U 62840

    27. Tresprostinil

    28. Trevyent

    29. U-62,840

    30. Treprostinil [mi]

    31. Treprostinil [inn]

    32. Treprostinil [jan]

    33. Treprostinil [usan]

    34. Treprostinil [vandf]

    35. Treprostinil Pound>>ut-15

    36. Treprostinil [mart.]

    37. Treprostinil [who-dd]

    38. 15au

    39. Gtpl5820

    40. Schembl4349618

    41. Treprostinil (jan/usan/inn)

    42. Chembl1237119

    43. Lrx -15

    44. Dtxsid901021654

    45. Hms3648g07

    46. Treprostinil [orange Book]

    47. Amy22230

    48. Bcp10253

    49. Ex-a1414

    50. Zinc3800475

    51. Mfcd00888847

    52. Akos027470173

    53. Cs-7872

    54. Db00374

    55. Ncgc00343944-03

    56. ({(1r,2r,3as,9as)-2-hydroxy-1-[(3s)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1h-cyclopenta[b]naphthalen-5-yl}oxy)acetic Acid

    57. 2-[[(1r,2r,3as,9as)-2,3,3a,4,9,9a-hexahydro-2-hydroxy-1-[(3s)-3-hydroxyoctyl]-1h-benz[f]inden-5-yl]oxy]acetic Acid

    58. Ac-30207

    59. As-56364

    60. L606

    61. Hy-100441

    62. D06213

    63. Sr-01000946210

    64. Q3495231

    65. Sr-01000946210-1

    66. Brd-k19706299-001-01-4

    67. [[(1r,2r,3as,9as)-2,3,3a,4,9,9a-hexahydro-2-hydroxy-1-[(s)-3-hydroxyoctyl]-1h-benzo[f]indene-5-yl]oxy]acetic Acid

    68. [[(1r,2r,3as,9as)-2,3,4,9,9a-hexahydro-2-hydroxy-1-[(3s)-3-hydroxyoctyl]-1h-benz[f]inden-5-yl]oxy]acetic Acid

    69. 2-((1r,2r,3as,9as)-2-hydroxy-1-((s)-3-hydroxyoctyl)-2,3,3a,4,9,9a-hexahydro-1h-cyclopenta[b]naphthalen-5-yloxy)acetic Acid

    70. 2-[[(1r,2r,3as,9as)-2,3,4,9,9a-hexahydro-2-hydroxy-1-[(3s)-3-hydroxyoctyl]-1h-benz[f]inden-5-yl]oxy]-acetic Acid

    71. 2-[[(2r,3r,3as,9as)-2-hydroxy-3-[(3s)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1h-cyclopenta[g]naphthalen-8-yl]oxy]acetic Acid

    72. 2-{[(1r,2r,3as,9as)-2-hydroxy-1-[(3s)-3-hydroxyoctyl]-1h,2h,3h,3ah,4h,9h,9ah-cyclopenta[b]naphthalen-5-yl]oxy}acetic Acid

    73. Acetic Acid, (((1r,2r,3as,9as)-2,3,3a,4,9,9a-hexahydro-2-hydroxy-1-((3s)-3-hydroxyoctyl)-1h-benz(f)inden-5-yl)oxy)-

    74. Acetic Acid, ((2,3,3a,4,9,9a-hexahydro-2-hydroxy-1-(3-hydroxyoctyl)-1h-benz(f)inden-5-yl)oxy)-, (1r-(1alpha(s*),2beta,3aalpha,9aalpha))-

    75. Acetic Acid,(((1r,2r,3as,9as)-2,3,3a,4,9,9a-hexahydro-2-hydroxy-1-((3s)-3-hydroxyoctyl)-1h-benz(f)inden-5-yl)oxy)-

    2.4 Create Date
    2006-07-28
    3 Chemical and Physical Properties
    Molecular Weight 390.5 g/mol
    Molecular Formula C23H34O5
    XLogP34.5
    Hydrogen Bond Donor Count3
    Hydrogen Bond Acceptor Count5
    Rotatable Bond Count10
    Exact Mass390.24062418 g/mol
    Monoisotopic Mass390.24062418 g/mol
    Topological Polar Surface Area87 Ų
    Heavy Atom Count28
    Formal Charge0
    Complexity495
    Isotope Atom Count0
    Defined Atom Stereocenter Count5
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Information
    1 of 4  
    Drug NameRemodulin
    PubMed HealthTreprostinil
    Drug ClassesAntihypertensive, Cardiovascular Agent, Platelet Aggregation Inhibitor, Vasodilator
    Drug LabelRemodulin (treprostinil) Injection is a sterile solution of treprostinil formulated for subcutaneous or intravenous administration. Remodulin is supplied in 20 mL multidose vials in four strengths, containing 20 mg, 50 mg, 100 mg, or 200 mg (1 mg/mL,...
    Active IngredientTreprostinil
    Dosage FormInjectable
    RouteIv (infusion), subcutaneous
    Strength1mg/ml; 2.5mg/ml; 10mg/ml; 5mg/ml
    Market StatusPrescription
    CompanyUnited Therap

    2 of 4  
    Drug NameTyvaso
    PubMed HealthTreprostinil (By breathing)
    Drug ClassesVasodilator
    Drug LabelTyvaso is a sterile formulation of treprostinil intended for administration by oral inhalation using the Tyvaso Inhalation System. Tyvaso is supplied in 2.9 mL low density polyethylene (LDPE) ampules, containing 1.74 mg treprostinil (0.6 mg/mL). Each...
    Active IngredientTreprostinil
    Dosage FormSolution
    RouteInhalation
    Strengtheq 0.6mg base/ml
    Market StatusPrescription
    CompanyUnited Therap

    3 of 4  
    Drug NameRemodulin
    PubMed HealthTreprostinil
    Drug ClassesAntihypertensive, Cardiovascular Agent, Platelet Aggregation Inhibitor, Vasodilator
    Drug LabelRemodulin (treprostinil) Injection is a sterile solution of treprostinil formulated for subcutaneous or intravenous administration. Remodulin is supplied in 20 mL multidose vials in four strengths, containing 20 mg, 50 mg, 100 mg, or 200 mg (1 mg/mL,...
    Active IngredientTreprostinil
    Dosage FormInjectable
    RouteIv (infusion), subcutaneous
    Strength1mg/ml; 2.5mg/ml; 10mg/ml; 5mg/ml
    Market StatusPrescription
    CompanyUnited Therap

    4 of 4  
    Drug NameTyvaso
    PubMed HealthTreprostinil (By breathing)
    Drug ClassesVasodilator
    Drug LabelTyvaso is a sterile formulation of treprostinil intended for administration by oral inhalation using the Tyvaso Inhalation System. Tyvaso is supplied in 2.9 mL low density polyethylene (LDPE) ampules, containing 1.74 mg treprostinil (0.6 mg/mL). Each...
    Active IngredientTreprostinil
    Dosage FormSolution
    RouteInhalation
    Strengtheq 0.6mg base/ml
    Market StatusPrescription
    CompanyUnited Therap

    4.2 Drug Indication

    For use as a continuous subcutaneous infusion or intravenous infusion (for those not able to tolerate a subcutaneous infusion) for the treatment of pulmonary arterial hypertension in patients with NYHA Class II-IV symptoms to diminish symptoms associated with exercise.

    FDA Label

    Treatment of adult patients with WHO Functional Class (FC) III or IV and:

    - inoperable chronic thromboembolic pulmonary hypertension (CTEPH), or

    - persistent or recurrent CTEPH after surgical treatment

    to improve exercise capacity.

    Treatment of pulmonary arterial hypertension

    5 Pharmacology and Biochemistry
    5.1 Pharmacology

    Pulmonary arterial hypertension (PAH) is a disease in which blood pressure is abnormally high in the arteries between the heart and lungs. PAH is characterized by symptoms of shortness of breath during physical exertion. The condition can ultimately lead to heart failure. Treprostinil is a potent oral antiplatelet agent. The major pharmacologic actions of treprostinil are direct vasodilation of pulmonary and systemic arterial vascular beds and inhibition of platelet aggregation. In animals, the vasodilatory effects reduce right and left ventricular afterload and increase cardiac output and stroke volume. Other studies have shown that treprostinil causes a dose-related negative inotropic and lusitropic effect. No major effects on cardiac conduction have been observed.

    5.2 MeSH Pharmacological Classification

    Antihypertensive Agents

    Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)

    5.3 FDA Pharmacological Classification
    5.3.1 Active Moiety
    TREPROSTINIL
    5.3.2 FDA UNII
    RUM6K67ESG
    5.3.3 Pharmacological Classes
    Prostaglandins I [CS]; Vasodilation [PE]; Prostacycline Vasodilator [EPC]
    5.4 ATC Code

    B01AC21

    B - Blood and blood forming organs

    B01 - Antithrombotic agents

    B01A - Antithrombotic agents

    B01AC - Platelet aggregation inhibitors excl. heparin

    B01AC21 - Treprostinil

    5.5 Absorption, Distribution and Excretion

    Absorption

    Relatively rapid and complete after subcutaneous infusion, with an absolute bioavailability approximately 100%. In patients with mild (n=4) or moderate (n=5) hepatic insufficiency and portopulmonary hypertension following a subcutaneous dose of 10 ng per kg of body weight per min for 150 mins the AUC 0-∞ was increased 3-fold and 5-fold respectively.

    Volume of Distribution

    14 L/70 kg

    5.6 Metabolism/Metabolites

    Substantially metabolized by the liver, but the precise enzymes responsible are unknown. Five metabolites have been described (HU1 through HU5) however, the biological activity and metabolic fate of these are unknown. The chemical structure of HU1 is unknown. The metabolite HU5 is the glucuronide conjugate of treprostinil. The other metabolites are formed by oxidation of the 3-hydroxyoctyl side chain (HU2) and subsequent additional oxidation (HU3) or dehydration (HU4). Study results of in vitro human hepatic cytochrome P450 demonstrates that treprostinil does not inhibit CYP-1A2, 2C9, 2C19, 2D6, 2E1, or 3A. There have been no studies that evaluate the potential of treprostinil to induce these enzymes.

    5.7 Biological Half-Life

    Terminal elimination half-life is approximately 2 to 4 hours. Plasma half-life is 34 and 85 minutes for intravenous and subcutaneous infusion of the drug, respectively.

    5.8 Mechanism of Action

    The major pharmacological actions of treprostinil are direct vasodilation of pulmonary and systemic arterial vascular beds and inhibition of platelet aggregation. In addition to treprostinil's direct vasodilatory effects, it also inhibits inflammatory cytokine. As a synthetic analogue of prostacyclin, it binds to the prostacyclin receptor, which subsequently induces the aforementioned downstream effects.

    API SUPPLIERS

    read-more
    read-more

    01

    Chirogate International

    Taiwan

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Global ChemShow
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothChirogate is a professional Prostaglandin manufacturer.

    Contact Supplier Contact Supplier
    Flag Taiwan
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF arrow-down Click Us! arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 28340

    Submission : 2016-08-15

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 68245-0008

    Start Marketing Date : 2010-01-01

    End Marketing Date : 2026-12-31

    Dosage Form (Strength) : POWDER (1g/g)

    Marketing Category : BULK INGREDIENT

     KDMF VMF Others AUDIT
    Chirogate CB

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Nuray Chemicals Private Limited

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Global ChemShow
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothNuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2017-02-16

    Pay. Date : 2016-09-20

    DMF Number : 30861

    Submission : 2016-09-27

    Status : Active

    Type : II

     CEP/COS JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2024-02-20

    Valid Till : 2026-12-06

    Written Confirmation Number : WC-0416

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 58159-041

    Start Marketing Date : 2016-07-25

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (35kg/35kg)

    Marketing Category : BULK INGREDIENT

     KDMF VMF Others AUDIT
    Nuray Chemicals

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    EUROAPI

    France

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Global ChemShow
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothEUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2017-05-23

    Pay. Date : 2016-11-25

    DMF Number : 31145

    Submission : 2016-12-09

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 82231-115

    Start Marketing Date : 2019-11-28

    End Marketing Date : 2026-12-31

    Dosage Form (Strength) : POWDER (1g/g)

    Marketing Category : BULK INGREDIENT

     KDMF VMF Others AUDIT arrow-down
    EUROAPI Compnay Banner

    04

    ChemWerth Inc

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Global ChemShow
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    Chemwerth Compnay Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    LGM Pharma

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Global ChemShow
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    LGM Pharma CB

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Dr. Reddy's Laboratories

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    CPhI Milan
    Booth #5D18
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF ASMF arrow-down
    ✖
    Available Reg Filing : ASMF
    AUDIT arrow-down
    Dr Reddy Company Banner

    07

    HRV Pharma

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Global ChemShow
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothHRV Pharma - Market Expansion Leader in Pharmaceuticals.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF AU arrow-down
    ✖
    Available Reg Filing : AU
    AUDIT
    HRV Global Life Sciences

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Chirogate International

    Taiwan

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Global ChemShow
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothChirogate is a professional Prostaglandin manufacturer.

    Contact Supplier Contact Supplier
    Flag Taiwan
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2015-01-06

    Pay. Date : 2014-07-15

    DMF Number : 28458

    Submission : 2014-09-16

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 68245-0009

    Start Marketing Date : 2010-01-01

    End Marketing Date : 2026-12-31

    Dosage Form (Strength) : POWDER (1g/g)

    Marketing Category : BULK INGREDIENT

     KDMF VMF Others AUDIT
    Chirogate CB

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Chirogate International

    Taiwan

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Global ChemShow
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothChirogate is a professional Prostaglandin manufacturer.

    Contact Supplier Contact Supplier
    Flag Taiwan
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 29207

    Submission : 2015-08-12

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    Chirogate CB

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Nuray Chemicals Private Limited

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Global ChemShow
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothNuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF CEP/COS JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 58159-040

    Start Marketing Date : 2016-06-14

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (35kg/35kg)

    Marketing Category : BULK INGREDIENT

     KDMF VMF Others AUDIT
    Nuray Chemicals

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    API Reference Price

    read-more
    read-more
    [{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1654453800,"product":"TREPROSTINIL SODIUM","address":"25, 12TH CROSS STREET, SHASTRI NAGAR,","city":"CHENNAI\/TAMILNADU","supplier":"NURAY CHEMICALS PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"ISTANBUL","customer":"THE PURCHASE MANAGER","customerCountry":"TURKEY","quantity":"0.15","actualQuantity":"145","unit":"GMS","unitRateFc":"380","totalValueFC":"54245.8","currency":"USD","unitRateINR":29186.206896551725,"date":"06-Jun-2022","totalValueINR":"4232000","totalValueInUsd":"54245.8","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"1919022","productDescription":"API","marketType":"","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"25, 12TH CROSS STREET, SHASTRI NAGAR,, CHENNAI\/TAMILNADU","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1656009000,"product":"TREPROSTINIL SODIUM(QTY:0.001 KGS)","address":"MSN HOUSE, PLOT NO. C-24,INDUSTRIAL HYDERABAD","city":"HYDERABAD","supplier":"MSN LABORATORIES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"BRUSSELS","customer":"UNDISCLOSED","customerCountry":"BELGIUM","quantity":"0.00","actualQuantity":"0.001","unit":"KGS","unitRateFc":"3000000","totalValueFC":"2973.8","currency":"USD","unitRateINR":232000000,"date":"24-Jun-2022","totalValueINR":"232000","totalValueInUsd":"2973.8","indian_port":"HYDERABAD AIR","hs_no":"29029040","bill_no":"2369435","productDescription":"API","marketType":"REGULATED MARKET","country":"BELGIUM","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"MSN HOUSE, PLOT NO. C-24,INDUSTRIAL HYDERABAD, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1664303400,"product":"PHARMACEUTICAL RAW MATERIAL TREPROSTINIL","address":"T-184, MIDC, BHOSARI,,PUNE","city":"PUNE,MAHARASHTRA","supplier":"EMCURE PHARMACEUTICALS LTD","supplierCountry":"INDIA","foreign_port":"ISTANBUL","customer":"POLIFARMA ILAC SANVE TICAS","customerCountry":"TURKEY","quantity":"0.05","actualQuantity":"0.05","unit":"KGS","unitRateFc":"350000","totalValueFC":"16932.6","currency":"USD","unitRateINR":27140000,"date":"28-Sep-2022","totalValueINR":"1357000","totalValueInUsd":"16932.6","indian_port":"BOMBAY AIR","hs_no":"29182110","bill_no":"4485752","productDescription":"API","marketType":"","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"T-184, MIDC, BHOSARI,,PUNE, PUNE,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1743445800,"product":"TREPROSTINIL SODIUM(TRADER TAX INVOICE NO:DEX\/24-25\/011 DATE:27.03.2025)","address":"Lakshmi Nilayam, Flat No.24, Plot No.29 B, Road No.8, FilmNagar","city":"Hyderabad","supplier":"RYPTUS LIFE SCIENCES LLP","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES, BA","customer":"LAFEDAR S A","customerCountry":"ARGENTINA","quantity":"0.01","actualQuantity":"10","unit":"GMS","unitRateFc":"750","totalValueFC":"7484","currency":"USD","unitRateINR":64064.732999999993,"date":"01-Apr-2025","totalValueINR":"640647.33","totalValueInUsd":"7484","indian_port":"Hyderabad Air","hs_no":"29420090","bill_no":"9575274","productDescription":"API","marketType":"","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"Lakshmi Nilayam, Flat No.24, Plot No.29 B, Road No.8, FilmNagar, Hyderabad","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q4","strtotime":1760553000,"product":"TREPROSTINIL SODIUM","address":"FIRST FLOOR","city":"CHENNAI","supplier":"STHREE CHEMICALS PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"FRANKFURT\/MAIN INT\\'L","customer":"THE PURCHASE MANAGER","customerCountry":"GERMANY","quantity":"0.30","actualQuantity":"300","unit":"GMS","unitRateFc":"202.2","totalValueFC":"60136.1","currency":"USD","unitRateINR":17714.1937,"date":"16-Oct-2025","totalValueINR":"5314258.11","totalValueInUsd":"60136.1","indian_port":"Bangalore Air","hs_no":"29420090","bill_no":"6216118","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"Bangalore Air","supplierAddress":"FIRST FLOOR, CHENNAI","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1673893800,"product":"TREPROSTINIL","address":"H.NO. 8-2-337,BESIDE TV9 OFFICE","city":"HYDERABAD ANDHRA PRADESH","supplier":"DR REDDY'S LABORATORIES EU LTD","supplierCountry":"UNITED KINGDOM","foreign_port":"N\/A","customer":"DR REDDY'S LABORATORIES","customerCountry":"INDIA","quantity":"0.70","actualQuantity":"700","unit":"GMS","unitRateFc":"1128.1","totalValueFC":"808408.6","currency":"USD","unitRateINR":"94421.5","date":"17-Jan-2023","totalValueINR":"66095055","totalValueInUsd":"808408.6","indian_port":"Vizag-EPZ\/SEZ","hs_no":"29420090","bill_no":"1000077","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"N\/A","supplierAddress":"N\/A","customerAddress":"H.NO. 8-2-337,BESIDE TV9 OFFICE"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1676226600,"product":"TREPROSTINIL","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE,,","city":"HYDERABAD,TELANGANA","supplier":"DR REDDY'S LABORATORIES EU LTD","supplierCountry":"UNITED KINGDOM","foreign_port":"N\/A","customer":"DR REDDY'S LABORATORIES","customerCountry":"INDIA","quantity":"0.67","actualQuantity":"669","unit":"GMS","unitRateFc":"1564.2","totalValueFC":"1048486.7","currency":"USD","unitRateINR":"129438.8","date":"13-Feb-2023","totalValueINR":"86594543","totalValueInUsd":"1048486.7","indian_port":"Vizag-EPZ\/SEZ","hs_no":"29420090","bill_no":"1000264","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"N\/A","supplierAddress":"N\/A","customerAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE,,"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1696271400,"product":"TREPROSTINIL LH15163S02","address":"H.NO. 8-2-337,BESIDE TV9 OFFICE","city":"HYDERABAD ANDHRA PRADESH","supplier":"DR REDDY'S LABORATORIES EU LTD","supplierCountry":"UNITED KINGDOM","foreign_port":"N\/A","customer":"DR REDDY'S LABORATORIES","customerCountry":"INDIA","quantity":"1.45","actualQuantity":"1447","unit":"GMS","unitRateFc":"757","totalValueFC":"1106188.2","currency":"USD","unitRateINR":"63626.3","date":"03-Oct-2023","totalValueINR":"92067269","totalValueInUsd":"1106188.2","indian_port":"Vizag-EPZ\/SEZ","hs_no":"29420090","bill_no":"1001833","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"N\/A","supplierAddress":"N\/A","customerAddress":"H.NO. 8-2-337,BESIDE TV9 OFFICE"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1742236200,"product":"TREPROSTINIL","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE,,","city":"HYDERABAD,TELANGANA","supplier":"DR REDDY'S LABORATORIES EU LTD","supplierCountry":"UNITED KINGDOM","foreign_port":"HEATHROW APT\/LONDON","customer":"DR REDDY'S LABORATORIES","customerCountry":"INDIA","quantity":"0.65","actualQuantity":"0.646","unit":"KGS","unitRateFc":"1854147.2","totalValueFC":"1214130","currency":"USD","unitRateINR":"162794128.4","date":"18-Mar-2025","totalValueINR":"105165006.94","totalValueInUsd":"1214130","indian_port":"Vizag-EPZ\/SEZ","hs_no":"29375000","bill_no":"8956181","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"HEATHROW APT\/LONDON","supplierAddress":"Steanard Lane Mirfield West Yorkshire WF14 8HZ SDNF United Kingdom","customerAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE,,"}]
    06-Jun-2022
    16-Oct-2025
    KGS
    overview
    Loading...

    Average Price (USD/KGS)

    Number of Transactions

    Total Quantity (KGS)

    Total Value (USD)

    Quantity (KGS) & Unit rate (USD/KGS) over time

    API/FDF Prices: Book a Demo to explore the features and consider upgrading later

    API Imports and Exports

    Importing Country Total Quantity
    (KGS)    		 Average Price
    (USD/KGS)    		 Number of Transactions

    Upgrade, download data, analyse, strategize, subscribe with us contact

    Drugs in Development

    read-more
    read-more
    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Dr. Reddy's Laboratories Announces the Launch of Treprostinil Injection in the U.S.

    Details:

    Treprostinil are direct vasodilation of pulmonary and systemic arterial vascular beds, and inhibition of platelet aggregation. It is indicated for the treatment for pulmonary arterial hypertension.


    Lead Product(s): Treprostinil Sodium,Inapplicable

    Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Remodulin-Generic

    Study Phase: Approved FDFProduct Type: Miscellaneous

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable April 21, 2023

    Dr Reddy Company Banner

    01

    Dr. Reddy's Laboratories

    India
    arrow
    CPhI Milan
    Booth #5D18
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Lead Product(s) : Treprostinil Sodium,Inapplicable

    Therapeutic Area : Cardiology/Vascular Diseases

    Highest Development Status : Approved FDF

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Dr. Reddy's Laboratories Announces the Launch of Treprostinil Injection in the U.S.

    Details : Treprostinil are direct vasodilation of pulmonary and systemic arterial vascular beds, and inhibition of platelet aggregation. It is indicated for the treatment for pulmonary arterial hypertension.

    Product Name : Remodulin-Generic

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    April 21, 2023

    Dr Reddy Company Banner

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Dr. Reddy's Gets CDSCO Panel Nod to Manufacture & Market Treprostinil Solution for Infusion

    Details:

    Treprostinil is a solution for infusion and act as platelet aggregation, which being evaluated for the treatment of patients with pulmonary arterial hypertension.


    Lead Product(s): Treprostinil Sodium,Inapplicable

    Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Remodulin-Generic

    Study Phase: Approved FDFProduct Type: Miscellaneous

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable March 12, 2022

    Dr Reddy Company Banner

    02

    Dr. Reddy's Laboratories

    India
    arrow
    CPhI Milan
    Booth #5D18
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Lead Product(s) : Treprostinil Sodium,Inapplicable

    Therapeutic Area : Cardiology/Vascular Diseases

    Highest Development Status : Approved FDF

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Dr. Reddy's Gets CDSCO Panel Nod to Manufacture & Market Treprostinil Solution for Infusion

    Details : Treprostinil is a solution for infusion and act as platelet aggregation, which being evaluated for the treatment of patients with pulmonary arterial hypertension.

    Product Name : Remodulin-Generic

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    March 12, 2022

    Dr Reddy Company Banner

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Inhaled Treprostinil Effect on Exercise in Pulmonary Hypertension

    Details:

    Treprostinil is a Other Small Molecule drug candidate, which is currently being evaluated in Phase I clinical studies for the treatment of Hypertension, Pulmonary.


    Lead Product(s): Treprostinil Sodium,Inapplicable

    Therapeutic Area: Pulmonary/Respiratory Diseases Brand Name: Undisclosed

    Study Phase: Phase IProduct Type: Miscellaneous

    Sponsor: United Therapeutics

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable August 11, 2025

    blank

    03

    University of California, San Diego

    Country
    arrow
    Global ChemShow
    Not Confirmed

    University of California, San Diego

    Country
    arrow
    Global ChemShow
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Treprostinil Sodium,Inapplicable

    Therapeutic Area : Pulmonary/Respiratory Diseases

    Highest Development Status : Phase I

    Partner/Sponsor/Collaborator : United Therapeutics

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Inhaled Treprostinil Effect on Exercise in Pulmonary Hypertension

    Details : Treprostinil is a Other Small Molecule drug candidate, which is currently being evaluated in Phase I clinical studies for the treatment of Hypertension, Pulmonary.

    Product Name : Undisclosed

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    August 11, 2025

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients with Hypoxemia

    Details:

    Treprostinil is a Other Small Molecule drug candidate, which is currently being evaluated in Phase I clinical studies for the treatment of Pulmonary Disease, Chronic Obstructive.


    Lead Product(s): Treprostinil Sodium,Inapplicable

    Therapeutic Area: Pulmonary/Respiratory Diseases Brand Name: Undisclosed

    Study Phase: Phase IProduct Type: Miscellaneous

    Sponsor: Yuh Chin T Huang, MD, MHS

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable June 26, 2025

    blank

    04

    United Therapeutics

    U.S.A
    arrow
    Global ChemShow
    Not Confirmed

    United Therapeutics

    U.S.A
    arrow
    Global ChemShow
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Treprostinil Sodium,Inapplicable

    Therapeutic Area : Pulmonary/Respiratory Diseases

    Highest Development Status : Phase I

    Partner/Sponsor/Collaborator : Yuh Chin T Huang, MD, MHS

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients with Hypoxemia

    Details : Treprostinil is a Other Small Molecule drug candidate, which is currently being evaluated in Phase I clinical studies for the treatment of Pulmonary Disease, Chronic Obstructive.

    Product Name : Undisclosed

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    June 26, 2025

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Liquidia Gets $50M from HCRx After First YUTREPIA™ Sale

    Details:

    The financing for Treprostinil Sodium will support research targeting the Prostanoid IP receptor in pulmonary arterial hypertension.


    Lead Product(s): Treprostinil Sodium,Inapplicable

    Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Yutrepia

    Study Phase: Approved FDFProduct Type: Miscellaneous

    Sponsor: Healthcare Royalty

    Deal Size: $50.0 million Upfront Cash: Undisclosed

    Deal Type: Financing June 23, 2025

    blank

    05

    Liquidia Corporation

    U.S.A
    arrow
    Global ChemShow
    Not Confirmed

    Liquidia Corporation

    U.S.A
    arrow
    Global ChemShow
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Treprostinil Sodium,Inapplicable

    Therapeutic Area : Cardiology/Vascular Diseases

    Highest Development Status : Approved FDF

    Partner/Sponsor/Collaborator : Healthcare Royalty

    Deal Size : $50.0 million

    Deal Type : Financing

    DEALS_DEV arrow-down

    Liquidia Gets $50M from HCRx After First YUTREPIA™ Sale

    Details : The financing for Treprostinil Sodium will support research targeting the Prostanoid IP receptor in pulmonary arterial hypertension.

    Product Name : Yutrepia

    Product Type : Miscellaneous

    Upfront Cash : Undisclosed

    June 23, 2025

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    FDA Okays Liquidia’s YUTREPIA Inhalation for PAH and PH-ILD Patients

    Details:

    Yutrepia is an FDA-approved, inhaled dry-powder formulation of treprostinil indicated for the treatment of pulmonary hypertension.


    Lead Product(s): Treprostinil Sodium,Inapplicable

    Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Yutrepia

    Study Phase: Approved FDFProduct Type: Miscellaneous

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable May 23, 2025

    blank

    06

    Liquidia Corporation

    U.S.A
    arrow
    Global ChemShow
    Not Confirmed

    Liquidia Corporation

    U.S.A
    arrow
    Global ChemShow
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Treprostinil Sodium,Inapplicable

    Therapeutic Area : Cardiology/Vascular Diseases

    Highest Development Status : Approved FDF

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    FDA Okays Liquidia’s YUTREPIA Inhalation for PAH and PH-ILD Patients

    Details : Yutrepia is an FDA-approved, inhaled dry-powder formulation of treprostinil indicated for the treatment of pulmonary hypertension.

    Product Name : Yutrepia

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    May 23, 2025

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Corsair Completes Preclinical Program for Treprostinil Prodrug Patch

    Details:

    TRX-248 transdermal system, a once-daily transdermal patch delivering treprostinil, a prostaglandin mimetic, for the treatment of Pulmonary Arterial Hypertension (PAH).


    Lead Product(s): Treprostinil Sodium,Inapplicable

    Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Undisclosed

    Study Phase: PreclinicalProduct Type: Miscellaneous

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable March 17, 2025

    blank

    07

    Corsair Pharma

    U.S.A
    arrow
    Global ChemShow
    Not Confirmed

    Corsair Pharma

    U.S.A
    arrow
    Global ChemShow
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Treprostinil Sodium,Inapplicable

    Therapeutic Area : Cardiology/Vascular Diseases

    Highest Development Status : Preclinical

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Corsair Completes Preclinical Program for Treprostinil Prodrug Patch

    Details : TRX-248 transdermal system, a once-daily transdermal patch delivering treprostinil, a prostaglandin mimetic, for the treatment of Pulmonary Arterial Hypertension (PAH).

    Product Name : Undisclosed

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    March 17, 2025

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    United Therapeutics Completes Enrollment for TETON 1 Inhaled Treprostinil in IPF

    Details:

    Tyvaso (treprostinil sodium) inhalation solution is an approved prostaglandin agonist. It is under investigation for the treatment of pulmonary arterial hypertension.


    Lead Product(s): Treprostinil Sodium,Inapplicable

    Therapeutic Area: Pulmonary/Respiratory Diseases Brand Name: Tyvaso

    Study Phase: Phase IIIProduct Type: Miscellaneous

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable February 04, 2025

    blank

    08

    United Therapeutics

    U.S.A
    arrow
    Global ChemShow
    Not Confirmed

    United Therapeutics

    U.S.A
    arrow
    Global ChemShow
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Treprostinil Sodium,Inapplicable

    Therapeutic Area : Pulmonary/Respiratory Diseases

    Highest Development Status : Phase III

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    United Therapeutics Completes Enrollment for TETON 1 Inhaled Treprostinil in IPF

    Details : Tyvaso (treprostinil sodium) inhalation solution is an approved prostaglandin agonist. It is under investigation for the treatment of pulmonary arterial hypertension.

    Product Name : Tyvaso

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    February 04, 2025

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Pharmosa Biopharm Expands Liquida Collaboration for Smart Nebulizers

    Details:

    The agreement aims for the development and commercialization of L606, an inhaled, sustained-release formulation of treprostinil being evaluated for the treatment of PAH and PH-ILD.


    Lead Product(s): Treprostinil Sodium,Inapplicable

    Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Undisclosed

    Study Phase: Phase IIIProduct Type: Miscellaneous

    Sponsor: Liquidia Corporation

    Deal Size: $161.2 million Upfront Cash: $3.5 million

    Deal Type: Expanded Collaboration October 04, 2024

    blank

    09

    Pharmosa Biopharm

    Taiwan
    arrow
    Global ChemShow
    Not Confirmed

    Pharmosa Biopharm

    Taiwan
    arrow
    Global ChemShow
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Treprostinil Sodium,Inapplicable

    Therapeutic Area : Cardiology/Vascular Diseases

    Highest Development Status : Phase III

    Partner/Sponsor/Collaborator : Liquidia Corporation

    Deal Size : $161.2 million

    Deal Type : Expanded Collaboration

    DEALS_DEV arrow-down

    Pharmosa Biopharm Expands Liquida Collaboration for Smart Nebulizers

    Details : The agreement aims for the development and commercialization of L606, an inhaled, sustained-release formulation of treprostinil being evaluated for the treatment of PAH and PH-ILD.

    Product Name : Undisclosed

    Product Type : Miscellaneous

    Upfront Cash : $3.5 million

    October 04, 2024

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    United Therapeutics Completes Enrollment of TETON 2 Study for Inhaled Treprostinil

    Details:

    Tyvaso (treprostinil sodium) inhalation solution is an approved prostaglandin agonist. It is under investigation for the treatment of pulmonary arterial hypertension.


    Lead Product(s): Treprostinil Sodium,Inapplicable

    Therapeutic Area: Pulmonary/Respiratory Diseases Brand Name: Tyvaso

    Study Phase: Phase IIIProduct Type: Miscellaneous

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable July 10, 2024

    blank

    10

    United Therapeutics

    U.S.A
    arrow
    Global ChemShow
    Not Confirmed

    United Therapeutics

    U.S.A
    arrow
    Global ChemShow
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Treprostinil Sodium,Inapplicable

    Therapeutic Area : Pulmonary/Respiratory Diseases

    Highest Development Status : Phase III

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    United Therapeutics Completes Enrollment of TETON 2 Study for Inhaled Treprostinil

    Details : Tyvaso (treprostinil sodium) inhalation solution is an approved prostaglandin agonist. It is under investigation for the treatment of pulmonary arterial hypertension.

    Product Name : Tyvaso

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    July 10, 2024

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Related Excipient Companies

    Upload your portfolio for free, ask us

    Excipients by Applications

    Click here to find the perfect excipient manufacturers by their capabilities

    Coating Systems & Additives

    read-more
    read-more

    Lubricants & Glidants

    read-more
    read-more

    Fillers, Diluents & Binders

    read-more
    read-more

    Parenteral

    read-more
    read-more

    Taste Masking

    read-more
    read-more

    Topical

    read-more
    read-more

    Controlled & Modified Release

    read-more
    read-more

    Film Formers & Plasticizers

    read-more
    read-more

    Disintegrants & Superdisintegrants

    read-more
    read-more

    Solubilizers

    read-more
    read-more

    Granulation

    read-more
    read-more

    Coloring Agents

    read-more
    read-more

    Chewable & Orodispersible Aids

    read-more
    read-more

    Thickeners and Stabilizers

    read-more
    read-more

    Direct Compression

    read-more
    read-more

    Emulsifying Agents

    read-more
    read-more

    Surfactant & Foaming Agents

    read-more
    read-more

    API Stability Enhancers

    read-more
    read-more

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    DATA COMPILATION #PharmaFlow

    read-more
    read-more

    STOCK RECAP #PipelineProspector

    read-more
    read-more

    NEWS #PharmaBuzz

    read-more
    read-more

    Global Sales Information

    Do you need Business Intel? Ask us

    Market Place

    Do you need sourcing support? Ask us

    Patents & EXCLUSIVITIES

    Check the patents & exclusivity for this product

    ABOUT THIS PAGE

    Looking for 81846-19-7 / Treprostinil Sodium API manufacturers, exporters & distributors?

    Treprostinil Sodium manufacturers, exporters & distributors 1

    44

    PharmaCompass offers a list of Treprostinil Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Treprostinil Sodium manufacturer or Treprostinil Sodium supplier for your needs.

    Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Treprostinil Sodium manufacturer or Treprostinil Sodium supplier.

    PharmaCompass also assists you with knowing the Treprostinil Sodium API Price utilized in the formulation of products. Treprostinil Sodium API Price is not always fixed or binding as the Treprostinil Sodium Price is obtained through a variety of data sources. The Treprostinil Sodium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

    API | Excipient name

    Treprostinil Sodium

    Synonyms

    81846-19-7, Remodulin, Uniprost, Rumodolin, Orenitram, Tyvaso

    Cas Number

    81846-19-7

    Unique Ingredient Identifier (UNII)

    RUM6K67ESG

    About Treprostinil Sodium

    Treprostinil is a synthetic analogue of prostacyclin, used to treat pulmonary hypertension.

    Treprostinil Sodium Manufacturers

    A Treprostinil Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Treprostinil Sodium, including repackagers and relabelers. The FDA regulates Treprostinil Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Treprostinil Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

    click here to find a list of Treprostinil Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

    Treprostinil Sodium Suppliers

    A Treprostinil Sodium supplier is an individual or a company that provides Treprostinil Sodium active pharmaceutical ingredient (API) or Treprostinil Sodium finished formulations upon request. The Treprostinil Sodium suppliers may include Treprostinil Sodium API manufacturers, exporters, distributors and traders.

    click here to find a list of Treprostinil Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

    Treprostinil Sodium USDMF

    A Treprostinil Sodium DMF (Drug Master File) is a document detailing the whole manufacturing process of Treprostinil Sodium active pharmaceutical ingredient (API) in detail. Different forms of Treprostinil Sodium DMFs exist exist since differing nations have different regulations, such as Treprostinil Sodium USDMF, ASMF (EDMF), JDMF, CDMF, etc.

    A Treprostinil Sodium DMF submitted to regulatory agencies in the US is known as a USDMF. Treprostinil Sodium USDMF includes data on Treprostinil Sodium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Treprostinil Sodium USDMF is kept confidential to protect the manufacturer’s intellectual property.

    click here to find a list of Treprostinil Sodium suppliers with USDMF on PharmaCompass.

    Treprostinil Sodium KDMF

    In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

    Pharmaceutical companies submit a Treprostinil Sodium Drug Master File in Korea (Treprostinil Sodium KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Treprostinil Sodium. The MFDS reviews the Treprostinil Sodium KDMF as part of the drug registration process and uses the information provided in the Treprostinil Sodium KDMF to evaluate the safety and efficacy of the drug.

    After submitting a Treprostinil Sodium KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Treprostinil Sodium API can apply through the Korea Drug Master File (KDMF).

    click here to find a list of Treprostinil Sodium suppliers with KDMF on PharmaCompass.

    Treprostinil Sodium WC

    A Treprostinil Sodium written confirmation (Treprostinil Sodium WC) is an official document issued by a regulatory agency to a Treprostinil Sodium manufacturer, verifying that the manufacturing facility of a Treprostinil Sodium active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Treprostinil Sodium APIs or Treprostinil Sodium finished pharmaceutical products to another nation, regulatory agencies frequently require a Treprostinil Sodium WC (written confirmation) as part of the regulatory process.

    click here to find a list of Treprostinil Sodium suppliers with Written Confirmation (WC) on PharmaCompass.

    Treprostinil Sodium NDC

    National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Treprostinil Sodium as an active pharmaceutical ingredient (API).

    Finished drug products

    The FDA updates the NDC directory daily. The NDC numbers for Treprostinil Sodium API and other APIs are published in this directory by the FDA.

    Unfinished drugs

    The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

    Pharmaceutical companies that manufacture Treprostinil Sodium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

    Compounded drug products

    The NDC directory also contains data on finished compounded human drug products that contain Treprostinil Sodium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Treprostinil Sodium NDC to their finished compounded human drug products, they may choose to do so.

    click here to find a list of Treprostinil Sodium suppliers with NDC on PharmaCompass.

    Treprostinil Sodium GMP

    Treprostinil Sodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

    GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

    PharmaCompass offers a list of Treprostinil Sodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Treprostinil Sodium GMP manufacturer or Treprostinil Sodium GMP API supplier for your needs.

    Treprostinil Sodium CoA

    A Treprostinil Sodium CoA (Certificate of Analysis) is a formal document that attests to Treprostinil Sodium's compliance with Treprostinil Sodium specifications and serves as a tool for batch-level quality control.

    Treprostinil Sodium CoA mostly includes findings from lab analyses of a specific batch. For each Treprostinil Sodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

    Treprostinil Sodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Treprostinil Sodium EP), Treprostinil Sodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Treprostinil Sodium USP).

    Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
    For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search